A poxvirus of primates. II. Immunology
- PMID: 18605416
A poxvirus of primates. II. Immunology
Abstract
OrTeCa poxvirus shares antigens with Yaba virus, as evidenced by two-way crossreactions in complement-fixation and neutralization tests. Antibodies produced by vaccinia and monkeypox viruses showed weak complement-fixation reactions with OrTeCa viral antigen, but neutralization reactions were negative and cross protection in vivo was not demonstrated. OrTeCa and Yaba virus antisera both contained complement-fixing and neutralizing antibodies against swinepox virus, but swinepox antiserum had no antibodies to any other poxvirus. Long-lasting immunity to the OrTeCa pox disease was produced in monkeys and man by spontaneous infection or vaccination with OrTeCa poxvirus. Complement-fixing antibody titers could be measured in convalescence, but tended to drop to low levels or disappear thereafter. In contrast, neutralizing antibody titers remained high for 3 years, and monkeys that were challenged with OrTeCa virus were reFractory to a second infection.
Similar articles
-
A poxvirus of primates. I. Growth of the virus in vitro and comparison with other poxviruses.J Natl Cancer Inst. 1970 Nov;45(5):897-905. J Natl Cancer Inst. 1970. PMID: 18605415
-
Differences between extracellular and intracellular forms of poxvirus and their implications.Prog Med Virol. 1973;16:86-108. Prog Med Virol. 1973. PMID: 4356899 Review. No abstract available.
-
A comparative study of Tanapox and Yaba viruses.J Gen Virol. 1973 Apr;19(1):37-49. doi: 10.1099/0022-1317-19-1-37. J Gen Virol. 1973. PMID: 4360632 No abstract available.
-
Differences in clinical and convalescent-phase antibodies of Rhesus monkeys infected with monkey pox, tanapox, and Yaba poxviruses.Infect Immun. 1973 Apr;7(4):539-46. doi: 10.1128/iai.7.4.539-546.1973. Infect Immun. 1973. PMID: 4357602 Free PMC article.
-
Immunology 101 at poxvirus U: immune evasion genes.Semin Immunol. 2001 Feb;13(1):59-66. doi: 10.1006/smim.2000.0296. Semin Immunol. 2001. PMID: 11289800 Review.
Cited by
-
Therapeutic strategies to address monkeypox.Expert Rev Anti Infect Ther. 2022 Oct;20(10):1249-1252. doi: 10.1080/14787210.2022.2113058. Epub 2022 Aug 17. Expert Rev Anti Infect Ther. 2022. PMID: 35953443 Free PMC article.